{"created":"2021-03-01T06:31:25.901865+00:00","id":25907,"links":{},"metadata":{"_buckets":{"deposit":"a36f83bc-7346-4de0-a0de-23408f202d15"},"_deposit":{"id":"25907","owners":[],"pid":{"revision_id":0,"type":"depid","value":"25907"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00025907","sets":["432:1291:1292:1324","453:456"]},"item_7_alternative_title_1":{"attribute_name":"その他のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"Clinico-statistical Study on Autologous Blood Transfusion -Effect of Recombinant Human Erythropoietin (EPO) and Iron Preparations-"}]},"item_7_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1997-07","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1","bibliographicPageEnd":"43","bibliographicPageStart":"37","bibliographicVolumeNumber":"27","bibliographic_titles":[{"bibliographic_title":"新潟歯学会雑誌"},{"bibliographic_title":"新潟歯学会雑誌","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Two hundred and ninety-one operative cases, who received autologous blood transfusions in our department from June 1988 to December 1996, were studied clinico-statistically. There were 274 cases of jaw deformities, 8 cases of malignant tumors and 5 cases of benign tumors. Autologous blood transfusion increased year by year, and consequently the rate of autologous blood transfusion among blood transfusions was above 90% after 1995. Recently homologous blood transfusion have not been required except for malignant tumors. The effects of recombinant human erythropoietin (EPO) and iron preparations (Fe) were investigated. The results were as follows: In the EPO and Fe group, just after autologous blood collection of 800ml the mean values for Hb and Ht were 0.90 and 0.90 of the baseline values before autologous blood collection, respectively. And in 4 to 14 days after surgery the mean values were 0.96 and 0.96, respectively. In the EPO and Fe group, Hb and Ht recovered after the surgery more quickly than in the control group.","subitem_description_type":"Abstract"},{"subitem_description":"今回、当科における自己血輸血症例について検討し、エリスロポエチン(EPO)、鉄剤の効果についても若干の知見を得たので報告する｡対象は、最近8年7か月間に自己血輸血で手術を行った291症例とした｡自己血輸血症例数の年度別推移では、年々増加傾向にあり1995年以降は50症例を越すようになっていた｡それに伴い同種血輸血症例数が減少し、悪性腫瘍手術以外では同種血輸血の必要性がなくなっていた｡疾患別では顎変形症が274例,悪性腫瘍が8例,良性腫瘍が5例であった。EPO、鉄剤の効果について800ml採血症例をEPO、鉄剤投与群,、剤単独投与群、非投与群の3群に分類し検討した｡EPO、鉄剤投与群、鉄剤単独投与群、非投与群のヘモグロビン値の採血前値はそれぞれ13.0、13.2、14.8g/dlであり、この値を初期値とすると採血後、術後(4～14日)の初期値に対する比はEPO、鉄剤投与群では0.90から0.96、鉄剤単独投与群では0.86から0.88とそれぞれ上昇、非投与群では0.90から0.79へと減少した。また,ヘマトクリット値に関しては鉄剤+EPO投与群、鉄剤単独投与群、非投与群の採血前値はそれぞれ38.8%、38.9%、45.0%であり、採血後、術後の初期値に対する比はEPO、鉄剤投与群では0.90、0.96と上昇、鉄剤投与群ではそれぞれ0.89、非投与群では0.90、0.79と減少した。以上、EPO、鉄剤投与群で術後早期のヘモグロビン、ヘマトクリット値の回復が認められた。","subitem_description_type":"Abstract"}]},"item_7_full_name_3":{"attribute_name":"著者別名","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"152921","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Kaji, Masataka"}]},{"nameIdentifiers":[{"nameIdentifier":"152922","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Ohashi, Yasushi"}]},{"nameIdentifiers":[{"nameIdentifier":"152923","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Mutoh, Yuuichi"}]},{"nameIdentifiers":[{"nameIdentifier":"152924","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Takagi, Ritsuo"}]},{"nameIdentifiers":[{"nameIdentifier":"152925","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Hattori, Yukio"}]},{"nameIdentifiers":[{"nameIdentifier":"152926","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Fukuda, Jyunichi"}]},{"nameIdentifiers":[{"nameIdentifier":"152927","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Someya, Genji"}]}]},"item_7_publisher_7":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"新潟歯学会"}]},"item_7_select_19":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_7_source_id_11":{"attribute_name":"書誌レコードID","attribute_value_mlt":[{"subitem_source_identifier":"AN0018300X","subitem_source_identifier_type":"NCID"}]},"item_7_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"03850153","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"鍛冶, 昌孝"}],"nameIdentifiers":[{"nameIdentifier":"152914","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"大橋, 靖"}],"nameIdentifiers":[{"nameIdentifier":"152915","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"武藤, 祐一"}],"nameIdentifiers":[{"nameIdentifier":"152916","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"高木, 律男"}],"nameIdentifiers":[{"nameIdentifier":"152917","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"服部, 幸男"}],"nameIdentifiers":[{"nameIdentifier":"152918","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"福田, 純一"}],"nameIdentifiers":[{"nameIdentifier":"152919","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"染矢, 源治"}],"nameIdentifiers":[{"nameIdentifier":"152920","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-08-19"}],"displaytype":"detail","filename":"NS_27(1)_37-43.pdf","filesize":[{"value":"785.1 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"NS_27(1)_37-43.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/25907/files/NS_27(1)_37-43.pdf"},"version_id":"3600d49f-9a5d-4f00-b53c-03caa18ee966"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Autologous blood transfusion","subitem_subject_scheme":"Other"},{"subitem_subject":"自己血輸血","subitem_subject_scheme":"Other"},{"subitem_subject":"Erythropoietin","subitem_subject_scheme":"Other"},{"subitem_subject":"エリスロポエチン","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"当科における自己血輸血症例の検討 : エリスロポエチン, 鉄剤の効果も含めて","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"当科における自己血輸血症例の検討 : エリスロポエチン, 鉄剤の効果も含めて"},{"subitem_title":"当科における自己血輸血症例の検討 : エリスロポエチン, 鉄剤の効果も含めて","subitem_title_language":"en"}]},"item_type_id":"7","owner":"1","path":["456","1324"],"pubdate":{"attribute_name":"公開日","attribute_value":"2013-08-22"},"publish_date":"2013-08-22","publish_status":"0","recid":"25907","relation_version_is_last":true,"title":["当科における自己血輸血症例の検討 : エリスロポエチン, 鉄剤の効果も含めて"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2022-12-15T03:55:51.487280+00:00"}